Literature DB >> 22718822

Viral-load-dependent effects of liver injury and regeneration on hepatitis B virus replication in mice.

Yongjun Tian1, Wen-ling Chen, Cheng-fu Kuo, Jing-hsiung James Ou.   

Abstract

Hepatitis B virus (HBV) is a hepatotropic virus that can cause severe liver diseases. By conducting studies using four different transgenic mouse lines that carry either the wild-type HBV genome or the HBV genome incapable of expressing the X gene, we found that liver injury and regeneration induced by a partial hepatectomy (PHx) could have different effects on HBV replication depending on the mouse lines. Further studies using hydrodynamic injection to introduce different amounts of the HBV genomic DNA into the mouse liver revealed that liver injury and regeneration induced by PHx enhanced HBV replication when viral load was low and suppressed HBV replication when viral load was high. These effects of liver injury and regeneration on HBV were independent of the HBV X protein and apparently due to alpha and beta interferons (IFN-α/β), as the effects could be abolished by the injection of anti-IFN-α/β antibodies. Further analysis indicated that PHx could induce the expression of hepatocyte nuclear factor 3 gamma (HNF3γ) when viral load was low and activate the signal transducer and activator of transcription 3 (Stat3) and suppress the expression of the suppressor of cytokine signaling 3 (SOCS3) irrespective of viral load. As both HNF3γ and Stat3 are required to activate the HBV enhancer I to stimulate HBV gene expression and replication, these results provided an explanation to the viral-load-dependent effect of liver injury and regeneration on HBV replication. Our studies thus revealed a novel interaction between HBV and its host and provided important information for understanding HBV replication and pathogenesis during liver injury.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22718822      PMCID: PMC3446606          DOI: 10.1128/JVI.01087-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  21 in total

Review 1.  Liver regeneration.

Authors:  G K Michalopoulos; M C DeFrances
Journal:  Science       Date:  1997-04-04       Impact factor: 47.728

2.  Acute-phase response factor, increased binding, and target gene transcription during liver regeneration.

Authors:  C Trautwein; T Rakemann; M Niehof; S Rose-John; M P Manns
Journal:  Gastroenterology       Date:  1996-06       Impact factor: 22.682

3.  Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection.

Authors:  Priscilla L Yang; Alana Althage; Josan Chung; Francis V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-08       Impact factor: 11.205

4.  Increased secretion of tumour necrosis factor and interleukin 6 from isolated, perfused liver of rats after partial hepatectomy.

Authors:  M Iwai; T X Cui; H Kitamura; M Saito; T Shimazu
Journal:  Cytokine       Date:  2001-01-07       Impact factor: 3.861

5.  Enhancement of hepatitis B virus replication by its X protein in transgenic mice.

Authors:  Zhenming Xu; T S Benedict Yen; Lanying Wu; Charles R Madden; Wenjie Tan; Betty L Slagle; Jing-hsiung Ou
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

6.  Partial hepatectomy in the mouse: technique and perioperative management.

Authors:  Arin K Greene; Mark Puder
Journal:  J Invest Surg       Date:  2003 Mar-Apr       Impact factor: 2.533

7.  High-level hepatitis B virus replication in transgenic mice.

Authors:  L G Guidotti; B Matzke; H Schaller; F V Chisari
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

8.  Regulation of hepatitis B virus replication by the ras-mitogen-activated protein kinase signaling pathway.

Authors:  Yanyan Zheng; Jie Li; Deborah L Johnson; Jing-hsiung Ou
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

9.  Antibodies to tumor necrosis factor-alpha inhibit liver regeneration after partial hepatectomy.

Authors:  P Akerman; P Cote; S Q Yang; C McClain; S Nelson; G J Bagby; A M Diehl
Journal:  Am J Physiol       Date:  1992-10

10.  Effects of interferon-α/β on HBV replication determined by viral load.

Authors:  Yongjun Tian; Wen-ling Chen; Jing-hsiung James Ou
Journal:  PLoS Pathog       Date:  2011-07-28       Impact factor: 6.823

View more
  8 in total

Review 1.  Mechanisms of Hepatitis B Virus Persistence.

Authors:  Kuen-Nan Tsai; Cheng-Fu Kuo; Jing-Hsiung James Ou
Journal:  Trends Microbiol       Date:  2017-08-16       Impact factor: 17.079

2.  A MAVS/TICAM-1-independent interferon-inducing pathway contributes to regulation of hepatitis B virus replication in the mouse hydrodynamic injection model.

Authors:  Chean Ring Leong; Hiroyuki Oshiumi; Masaaki Okamoto; Masahiro Azuma; Hiromi Takaki; Misako Matsumoto; Kazuaki Chayama; Tsukasa Seya
Journal:  J Innate Immun       Date:  2014-08-08       Impact factor: 7.349

3.  Hepatitis B virus inhibits insulin receptor signaling and impairs liver regeneration via intracellular retention of the insulin receptor.

Authors:  Sebastian Robert Barthel; Regina Medvedev; Thekla Heinrich; Sarah Manon Büchner; Nadja Kettern; Eberhard Hildt
Journal:  Cell Mol Life Sci       Date:  2016-05-07       Impact factor: 9.261

Review 4.  Technical standards for hepatitis B virus X protein (HBx) research.

Authors:  Betty L Slagle; Ourania M Andrisani; Michael J Bouchard; Caroline G L Lee; J-H James Ou; Aleem Siddiqui
Journal:  Hepatology       Date:  2015-03-09       Impact factor: 17.425

Review 5.  Leptin-based adjuvants: an innovative approach to improve vaccine response.

Authors:  Sarah J White; Matthew J Taylor; Ryan T Hurt; Michael D Jensen; Gregory A Poland
Journal:  Vaccine       Date:  2013-01-29       Impact factor: 3.641

6.  Foxa3 induces goblet cell metaplasia and inhibits innate antiviral immunity.

Authors:  Gang Chen; Thomas R Korfhagen; Christopher L Karp; Soren Impey; Yan Xu; Scott H Randell; Joseph Kitzmiller; Yutaka Maeda; Hans Michael Haitchi; Anusha Sridharan; Albert P Senft; Jeffrey A Whitsett
Journal:  Am J Respir Crit Care Med       Date:  2014-02-01       Impact factor: 21.405

Review 7.  Emergence of Leptin in Infection and Immunity: Scope and Challenges in Vaccines Formulation.

Authors:  Dayakar Alti; Chandrasekaran Sambamurthy; Suresh K Kalangi
Journal:  Front Cell Infect Microbiol       Date:  2018-05-09       Impact factor: 5.293

Review 8.  Pathogenicity and virulence of Hepatitis B virus.

Authors:  Yu-Chen Chuang; Kuen-Nan Tsai; Jing-Hsiung James Ou
Journal:  Virulence       Date:  2022-12       Impact factor: 5.882

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.